Ada Health, the Berlin-based health app, just secured $90 million in a Series B funding round.
The round was led by Leaps by pharma company Bayer and included participating investors such as Samsung Catalyst Fund, Vitruvian Partners, among others.
The Ada Health app allows users to monitor their symptoms and keep track of their health using AI and clinical data.
Users download the app for free, answer some questions about their symptoms and receive advice.
Ada says it’s one of the clinically most accurate symptoms assessment apps according to studies.
The startup raised $47 million back in 2017, but has since been working to extend its assessment technology.
Prior to launching to the public, it was aimed at doctors to help them assess patient symptoms more rapidly.
To date, it’s been downloaded some 11 million times across 150 countries and supports 10 languages.
Ada Health also offers an enterprises suite for partners to integrate the technology into their websites. In that way, it can be used by medical practices to help patients get an instant assessment of their symptoms and a referral to see a doctor where necessary.
The advantage for doctors is that they get a pre-brief of the symptoms a patient turns up with. In that sense, it’s convenient and helps speed up appointments.
There’s little doubt that telehealth has place in the market, particularly in countries with nationalised health services like the UK where access to automated services is becoming ever more important due to high demand.